A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China
Clinical trial NCT05547243 · UNKNOWN
Trial details
- NCT number
- NCT05547243
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-26
- Primary completion
- 2022-12-23
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.